REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 126 filers reported holding REVOLUTION MEDICINES INC in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $269,000 | -8.5% | 10,700 | 0.0% | 0.03% | -14.7% |
| Q3 2021 | $294,000 | +5.4% | 10,700 | +21.6% | 0.03% | +6.2% |
| Q2 2021 | $279,000 | -30.9% | 8,800 | 0.0% | 0.03% | -25.6% |
| Q1 2021 | $404,000 | +16.1% | 8,800 | 0.0% | 0.04% | +22.9% |
| Q4 2020 | $348,000 | +13.7% | 8,800 | 0.0% | 0.04% | -10.3% |
| Q3 2020 | $306,000 | +10.1% | 8,800 | 0.0% | 0.04% | +5.4% |
| Q2 2020 | $278,000 | – | 8,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $139,040,000 | 34.79% |
| Ponoi II Management, LLC | 685,011 | $17,242,000 | 31.32% |
| Nextech Invest Ltd. | 2,968,214 | $74,710,000 | 19.68% |
| Ponoi Management, LLC | 685,011 | $17,242,000 | 15.90% |
| Column Group LLC | 3,347,245 | $84,250,000 | 11.46% |
| TRV GP IV, LLC | 1,419,900 | $35,739,000 | 10.28% |
| Cormorant Asset Management, LP | 2,431,852 | $61,210,000 | 3.64% |
| Boxer Capital, LLC | 3,484,264 | $87,699,000 | 3.41% |
| Casdin Capital, LLC | 2,370,000 | $59,653,000 | 1.68% |
| BVF INC/IL | 1,810,549 | $45,572,000 | 1.65% |